Eisai, Biogen (BIIB) Injectable-At-Home Alzheimer's Drug Demonstrates Encouraging Potential
Tweet Send to a Friend
Eisai Co., Ltd. and Biogen Inc. (Nasdaq: BIIB) announced today that Eisai presented new data for LEQEMBI® (lecanemab-irmb) 100 mg/mL ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
